Skip to content

Clinical trials

Phase 2 Sleep Initiation and Maintenance Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Phase 2 Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20121
20191
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia2
Canopy Growth Corporation1
Centre hospitalier de l'Université de Montréal (CHUM)1
GlaxoSmithKline1
Pfizer1
St. Joseph's Healthcare Hamilton1
University Health Network, Toronto1
University of Colorado, Denver1
University of Manitoba1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders10
Marijuana Abuse2
Anxiety Disorders1
Attention Deficit Disorder with Hyperactivity1
Autism Spectrum Disorder1
Delirium1
Emergence Delirium1
Major Depressive Disorder1
Pain1
Sleep Wake Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.